A US-based biotech company has successfully sequenced the genetic codes of preserved plants, some of which date back more ...

There are a number of tools and resources to help you “find your people,” including the Williamsburg Area Genealogical ...

Regeneron Pharmaceuticals (REGN) shares sank in Friday trading after the company published disappointing drug trial results ...

Regeneron and Sanofi's COPD drug itepekimab cut exacerbations by 27% in one Phase 3 trial, while the second trial did not ...

It's only a matter of time before cybercriminals begin to use artificial intelligence-enabled tools, open-source software and ...

As staffing levels shrink and workloads grow, a troubling trend is taking shape in the American workplace.A new report shows ...

Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

Helped by the deregulation of the sector in the 1980s and brilliant advertising, Mary Perkins and her husband Doug have taken ...

Regneron stock crashed today following disappointing COPD trials data. Here's what makes REGN shares worth buying on the ...

Duke Energy settled a class-action lawsuit over a data breach that happened last year, according to court documents from the ...

The show is the latest project in a career that has been dedicated to fostering inclusivity and advancing the graduation rates and success of underserved students in higher education. She came to ...

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) saw its stock touch a 52-week low of $518.68 as the biotech firm contends with ...